BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1825453)

  • 41. Baroreflex buffering of pressor response to vasopressin is mediated by V1, not V2, receptors in conscious rats.
    Shimizu K; Schwartz J; McGrath BP
    Am J Physiol; 1993 Feb; 264(2 Pt 2):R345-9. PubMed ID: 8447490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vasopressin and renin-angiotensin maintain arterial pressure during PEEP in nonexpanded, conscious dogs.
    Kaczmarczyk G; Vogel S; Krebs M; Bünger H; Scholz A
    Am J Physiol; 1996 Nov; 271(5 Pt 2):R1396-402. PubMed ID: 8945979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of novel selective hypotensive vasopressin peptides that exhibit little or no functional interactions with known oxytocin/vasopressin receptors.
    Chan WY; Wo NC; Stoev S; Cheng LL; Manning M
    Br J Pharmacol; 1998 Oct; 125(4):803-11. PubMed ID: 9831918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiovascular and renal responses to chronic vasopressin infusion.
    Brown AJ; Lohmeier TE; Carroll RG; Meydrech EF
    Am J Physiol; 1986 Apr; 250(4 Pt 2):H584-94. PubMed ID: 3515969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blocking effects of OPC-21268 and OPC-31260 (vasopressin V1- and V2-receptor antagonists) on vasopressin-induced constrictions in isolated, perfused dog femoral arteries.
    Chiba S; Tsukada M
    Jpn J Pharmacol; 1992 May; 59(1):133-5. PubMed ID: 1324373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanism of effect of alpha adrenergic stimulation with norepinephrine on renal water excretion.
    Schrier RW; Berl T
    J Clin Invest; 1973 Feb; 52(2):502-11. PubMed ID: 4683886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contribution of vasopressin to progression of chronic renal failure: study in Brattleboro rats.
    Bouby N; Hassler C; Bankir L
    Life Sci; 1999; 65(10):991-1004. PubMed ID: 10499867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of prostaglandin synthesis and the action of vasopressin during extracellular volume expansion in the dog.
    Kövér G; Szemerédi K; Tost H
    Acta Physiol Hung; 1983; 61(3):169-84. PubMed ID: 6650187
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antidiuresis and vasopressin release with hypoxemia and hypercapnia in conscious dogs.
    Rose CE; Anderson RJ; Carey RM
    Am J Physiol; 1984 Jul; 247(1 Pt 2):R127-34. PubMed ID: 6742223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma vasopressin concentration in high sodium renal hypertension.
    Hinojosa C; Shade RE; Haywood JR
    J Hypertens; 1986 Oct; 4(5):529-34. PubMed ID: 3794328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acutely elevated vasopressin increases circulating concentrations of cortisol and aldosterone in fasting northern elephant seal (Mirounga angustirostris) pups.
    Ortiz RM; Wade CE; Ortiz CL; Talamantes F
    J Exp Biol; 2003 Aug; 206(Pt 16):2795-802. PubMed ID: 12847125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N alpha-acetyl-[Arg8]vasopressin antagonizes the behavioral effect of [Cyt6]vasopressin-(5-9), but not of vasopressin.
    Kovács GL; Liu B; Burbach JP; Van Ree JM; De Wied D
    Eur J Pharmacol; 1989 Feb; 161(1):27-35. PubMed ID: 2721547
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vasopressin and angiotensin II in reflex regulation of heart rate: effect of water deprivation.
    Brooks VL
    Am J Physiol; 1992 Oct; 263(4 Pt 2):R756-61. PubMed ID: 1415785
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic and renal hemodynamic responses to vascular blockade of vasopressin in conscious dogs with ascites.
    Vari RC; Freeman RH; Davis JO; Sweet WD
    Proc Soc Exp Biol Med; 1985 Jun; 179(2):192-6. PubMed ID: 2986153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vascular effects alter early-gestation fetal renal responses to vasopressin.
    Ervin MG; Terry KA; Calvario GC; Castro R; Ross MG; Leake RD; Fisher DA
    Am J Physiol; 1994 Mar; 266(3 Pt 2):R722-9. PubMed ID: 8160865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contribution of the vasopressin V1 receptor to its hydrosmotic response.
    Yorio T; Satumtira N
    Biol Cell; 1989; 66(1-2):7-12. PubMed ID: 2529941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiovascular responses to V1-vasopressinergic antagonism in conscious versus anesthetized rats.
    Brizzee BL; Walker BR
    Can J Physiol Pharmacol; 1988 Nov; 66(11):1437-41. PubMed ID: 3242779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma vasopressin in blood pressure homeostasis and in experimental renal hypertension.
    Pullan PT; Johnston CI; Anderson WP; Korner PI
    Am J Physiol; 1980 Jul; 239(1):H81-7. PubMed ID: 7396022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vasopressin stimulates phosphatidylinositol turnover and aldosterone synthesis in rat adrenal glomerulosa cells: comparison with angiotensin II.
    Woodcock EA; Mcleod JK; Johnston CI
    Endocrinology; 1986 Jun; 118(6):2432-6. PubMed ID: 2938936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolism of vasopressin.
    Share L; Kimura T; Matsui K; Shade RE; Crofton JT
    Fed Proc; 1985 Jan; 44(1 Pt 1):59-61. PubMed ID: 3967770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.